Oct 2, 2023 08:02AM
Oct 2, 2023 08:00AM
Sep 29, 2023 10:00AM
Sep 29, 2023 10:00AM
Aug 8, 2023 07:00AM
Jun 30, 2023 12:31PM
Jun 30, 2023 12:30PM New Analysis of MRI Findings Shows UPLIZNA® (inebilizumab-cdon) Reduced the Formation of Subclinical Spinal Cord Lesions in People With Neuromyelitis Optica Spectrum Disorder (NMOSD)
Jun 26, 2023 11:00AM
Jun 26, 2023 11:00AM
Jun 22, 2023 08:02AM
Jun 22, 2023 08:00AM
Jun 17, 2023 05:00PM
Jun 17, 2023 02:00PM
Jun 12, 2023 08:05AM Horizon Therapeutics (HZNP) Reports Publication of UPLIZNA Data
Jun 12, 2023 08:00AM
Jun 5, 2023 08:00AM
May 2, 2023 09:25AM
May 1, 2023 08:00AM
Apr 20, 2023 08:00AM
Apr 14, 2023 08:16AM
Apr 14, 2023 08:15AM Horizon Therapeutics plc Announces FDA Approval of an Update to the Indication Language for TEPEZZA® (teprotumumab-trbw) to Specify its Use in Thyroid Eye Disease (TED) Patients Regardless of Disease
Apr 10, 2023 08:00AM
Mar 14, 2023 11:16AM
Mar 14, 2023 11:15AM
Mar 12, 2023 12:00PM
Feb 23, 2023 08:00AM
Jan 18, 2023 08:03AM
Jan 18, 2023 08:00AM Horizon Therapeutics plc Announces Phase 2 Trial Evaluating Dazodalibep for the Treatment of Sjögren’s Syndrome Meets Primary Endpoint in the Second Study Population; Only Phase 2 Trial to Meet Pri
Dec 20, 2022 08:00AM
Dec 12, 2022 06:00AM
Nov 23, 2022 06:00AM
Nov 16, 2022 08:15AM
Nov 2, 2022 07:00AM
Oct 26, 2022 08:00AM
Oct 22, 2022 10:30AM New Real-World Analysis of TEPEZZA® (teprotumumab-trbw) Use Indicates a Small Percentage of People Receive a Second Course of Treatment
Oct 13, 2022 08:00AM
Oct 12, 2022 08:00AM
Sep 29, 2022 08:00AM
Sep 14, 2022 08:00AM
Sep 12, 2022 08:00AM
Aug 29, 2022 04:00AM
Aug 3, 2022 07:00AM Horizon Therapeutics plc Reports Second-Quarter 2022 Financial Results and Revises Full-Year 2022 Net Sales and Adjusted EBITDA Guidance
Jul 8, 2022 08:00AM
Jun 15, 2022 08:33AM
Jun 15, 2022 08:30AM
Jun 11, 2022 10:00AM
Jun 1, 2022 08:00AM
May 24, 2022 08:00AM
May 4, 2022 07:00AM Horizon Therapeutics plc Reports First-Quarter 2022 Financial Results
May 2, 2022 06:27AM

322,195 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All